Clinical Risk State for Bipolar Disorder in Adolescents
Aim: The purpose of the study is to characterize the at-risk phases preceding a first episode of bipolar disorder and of schizophrenia, and to identify clinical and biological predictors of the disease development.
Hypothesis a: Over 6-24 months, 25% of at-risk youth will develop the full manifestations of Bipolar Disorder (BPD) or schizophrenia.
Hypothesis b: The symptoms utilized for characterizing the at-risk phase of BPD will differentiate between individuals developing BPD and schizophrenia.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Characterizing the Clinical Risk State for Bipolar Disorder in Adolescents|
- Development of a bipolar or schizophrenia disorder [ Time Frame: within 24 months ] [ Designated as safety issue: No ]
|Study Start Date:||September 2009|
|Estimated Study Completion Date:||May 2015|
|Estimated Primary Completion Date:||May 2015 (Final data collection date for primary outcome measure)|
Prospective, naturalistic, cohort study aiming to characterizing the bipolar and psychotic prodrome thoroughly with a variety of clinical and biological measures.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01383915
|Contact: Christoph U Correll, MDemail@example.com|
|United States, New York|
|The Zucker Hillside Hospital, NSLIJ||Recruiting|
|Glen Oaks, New York, United States, 11004|
|Contact: Christoph U Correll, MD 718-470-4812 firstname.lastname@example.org|
|Study Director:||Christoph Correll, MD||The Zucker Hillside Hospital, Feinstein Institute for Medical Research|